A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

Republican lawmakers have criticized institutions for allegedly misusing taxpayer money, citing cases such as the 2020 ...

A new report into the state of inflammatory bowel disease in Australia has revealed rates of the life long disease in the ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.